At the news
? NEUTRALIMPACT 3/10 144 filed Nov 12, 2026 at 17:59 ET
Samsara BioCapital, L.P., a major shareholder, filed Form 144 to sell 61,287 shares of vTv Therapeutics common stock, with an estimated aggregate market value of approximately $1.32 million. The sale is planned for the open market, and the filing indicates the insider has considered selling a portion of its holdings.
- Samsara BioCapital, L.P. filed Form 144 to sell 61,287 shares of vTv Therapeutics common stock.
- Estimated aggregate market value of the proposed sale is $1,315,831.89.
- Shares were acquired through open market purchases, a private placement, and a warrant exercise.
- The sale is planned for the open market via Merrill Lynch.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access